PRECIGEN, INC.
For the period ended Jun 30, 2025. Filed Aug 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 12, 2025
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the and
Condensed Consolidated Statements of Cash Flows
| Six Months Ended June 30, | ||
|---|---|---|
| (Amounts in thousands) | 2025 | 2024 |
| Cash flows from operating activities | ||
| Net loss | $(80,795) | $(82,530) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 1,259 | 3,191 |
| Loss (Gain) on disposals of assets, net | 14 | (3) |
| Impairment of goodwill | 3,907 | 1,630 |
| Impairment of other noncurrent assets | — | 32,915 |
| Change in fair value of warrant liabilities | 28,021 | — |
| Amortization of discounts on investments, net | (1,174) | (570) |
| Stock-based compensation expense | 4,315 | 4,545 |
| Shares issued as payment for services | 527 | 528 |
| Deferred income taxes | — | (1,718) |
| Changes in operating assets and liabilities: | ||
| Receivables: | ||
| Trade | 599 | 391 |
| Other | (4) | 490 |
| Prepaid expenses | 910 | 1,158 |
| Other assets | (215) | 55 |
| Accounts payable | 684 | 3,178 |
| Accrued compensation and benefits | 1,662 | 1,468 |
| Other accrued liabilities | 5,378 | (235) |
| Deferred revenue | (291) | (131) |
| Lease liabilities | (99) | 303 |
| Settlement and indemnification accruals | — | (1,862) |
| Net cash used in operating activities | (35,302) | (37,197) |
Condensed Consolidated Statements of Cash Flows
| Six Months Ended June 30, | ||
|---|---|---|
| (Amounts in thousands) | 2025 | 2024 |
| Cash flows from investing activities | ||
| Purchases of investments | $(38,875) | $(51,664) |
| Sales and maturities of investments | 62,448 | 97,335 |
| Purchases of property, plant and equipment | (1,588) | (6,674) |
| Proceeds from sale of assets | — | 3 |
| Net cash provided by investing activities | 21,985 | 39,000 |
| Cash flows from financing activities | ||
| Payment of issuance cost related to 2024 public offering of shares | (355) | — |
| Payments to taxing authorities in connection with shares directly withheld from employees | (1,776) | — |
| Proceeds from stock option exercises | 223 | 52 |
| Payment of issuance costs related to Series A Preferred Stock | (537) | — |
| Net cash (used in) provided by financing activities | (2,445) | 52 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 5 | (95) |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (15,757) | 1,760 |
| Cash, cash equivalents, and restricted cash | ||
| Beginning of period | 29,517 | 7,848 |
| End of period | $13,760 | $9,608 |
| Supplemental disclosure of cash flow information | ||
| Cash paid during the period for interest | $— | $5 |
| Cash paid during the period for income taxes | 3 | 4 |
| Significant noncash activities | ||
| Accrued compensation paid in equity awards | $3,578 | $3,039 |
| Purchases of property and equipment included in accounts payable and other accrued liabilities | $254 | $1,171 |
| Proceeds from sale of assets included in accounts receivable | — | 57 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.